Relay Therapeutics, Inc. (RLAY) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Relay Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
  • Relay Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.48 B, a 28.5% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.48 B -$329 M -28.5% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$1.4 B -$342 M -32.3% Dec 31, 2023 10-Q 2024-05-02
Q3 2023 -$1.32 B -$326 M -32.9% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$1.25 B -$344 M -38% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$1.15 B -$323 M -38.9% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$1.06 B -$291 M -37.8% Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$991 M -$290 M -41.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$907 M -$267 M -41.8% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$830 M -$384 M -86% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$768 M -$364 M -90% Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$701 M -$261 M -59.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$640 M -$399 M -165% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$446 M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$404 M -$215 M -113% Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$440 M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 -$241 M Jun 30, 2020 10-Q 2020-08-27
Q4 2019 -$189 M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.